JEFFREY L EDWARDS
CIK 1190642 · EVP, Fin & Bus. Dev., CFO · last filed 2026-06-17
JEFFREY L EDWARDS is an EVP, Fin & Bus. Dev., CFO who has filed 60 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for KYNB, was dated Jun 17, 2026. Across all open-market trades the lifetime net is −$59.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $570.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$570.9K
7
60
-$59.20M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KYNB | Director | — | $6.97 | — | $0 | 1 | 2026-06-17 |
| BIO.B | Director | 715 | $309.37 | $221.2K | $0 | 3 | 2026-04-23 |
| KYNTRA BIO, INC. (FGEN) Delisted | Director | 1,675 | $9.75 | $16.3K | -$135.6K | 11 | 2025-06-06 |
| LFCR | Director | 79,667 | $4.39 | $349.7K | $0 | 5 | 2024-07-10 |
| Clearside Biomedical, Inc. (CLSD) Delisted | Director | — | $0.35 | — | $0 | 7 | 2024-06-21 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Director | 12,457 | $8.76 | $109.1K | $0 | 5 | 2022-06-07 |
| ALLERGAN INC (AGN) Delisted | EVP, Fin & Bus. Dev., CFO | 58,153 | — | — | -$59.07M | 27 | 2014-02-25 |
Recent Filings
60 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-17 | KYNB | Grant (A) | — | $0 | EDGAR |
| 2026-04-23 | BIO.B | Mixed | +407 | $0 | EDGAR |
| 2025-06-06 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-04-24 | BIO.B | Mixed | +308 | $0 | EDGAR |
| 2024-09-10 | BIO.B | Grant (A) | — | $0 | EDGAR |
| 2024-07-10 | LFCR | Grant (A) | +30,000 | $0 | EDGAR |
| 2024-06-21 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-02 | LFCR | Exer (M) | +9,554 | $0 | EDGAR |
| 2023-06-23 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.